ArticleDiagnostics (Basel, Switzerland)2022
A Robust Framework for Data Generative and Heart Disease Prediction Based on Efficient Deep Learning Models.
Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 48 citations in OpenAlex.
- Sustainable and interpretable heart disease prediction: a clinical decision support approach for biomedical healthcare applications.Scientific reports · 2026Article
- A comprehensive survey of artificial intelligence methods for cardiovascular disease detection: Recent advances and future challenges.MethodsX · 2025Review
- Exploring the potential of cell-free RNA and Pyramid Scene Parsing Network for early preeclampsia screening.BMC pregnancy and childbirth · 2025Article
- A Real-Time Computer-Aided Diagnosis System for Coronary Heart Disease Prediction Using Clinical Information.Reviews in cardiovascular medicine · 2025Article
- Deep learning approach for cardiovascular disease risk stratification and survival analysis on a Canadian cohort.The international journal of cardiovascular imaging · 2024Article
- Quantum-inspired seagull optimised deep belief network approach for cardiovascular disease prediction.PeerJ. Computer science · 2024Article
- Machine Learning Analysis of RNA-seq Data for Diagnostic and Prognostic Prediction of Colon Cancer.Sensors (Basel, Switzerland) · 2023Article
- Using Recurrent Neural Networks for Predicting Type-2 Diabetes from Genomic and Tabular Data.Diagnostics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biomarkers including fasting blood sugar, heart rate, electrocardiogram (ECG), blood pressure, etc. are essential in the heart disease (HD) diagnosing. Using wearable sensors, these measures are collected and applied as inputs to a deep learning (DL) model for HD diagnosis. However, it is observed that model accuracy weakens when the data gathered are scarce or imbalanced. Therefore, this work proposes two DL-based frameworks, GAN-1D-CNN, and GAN-Bi-LSTM. These frameworks contain: (1) a generative adversarial network (GAN) and (2) a one-dimensional convolutional neural network (1D-CNN) or bi-directional long short-term memory (Bi-LSTM). The GAN model is utilized to augment the small and imbalanced dataset, which is the Cleveland dataset. The 1D-CNN and Bi-LSTM models are then trained using the enlarged dataset to diagnose HD. Unlike previous works, the proposed frameworks increase the dataset first to avoid the prediction bias caused by the limited data. The GAN-1D-CNN achieved 99.1% accuracy, specificity, sensitivity, F1-score, and 100% area under the curve (AUC). Similarly, the GAN-Bi-LSTM obtained 99.3% accuracy, 99.2% specificity, 99.3% sensitivity, 99.2% F1-score, and 100% AUC. Furthermore, time complexity of proposed frameworks is investigated with and without principal component analysis (PCA). The PCA method reduced prediction times for 61 samples using GAN-1D-CNN and GAN-Bi-LSTM to 68.8 and 74.8 ms, respectively. These results show that it is reliable to use our frameworks for augmenting limited data and predicting heart disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.